ACCELERATED MEDICAL DIAGNOSTICS, INC
Medtech · Private
InductDx diagnostic test using accelerator mass spectrometry to measure radiolabeled microdose drug-DNA damage in AML patient cells
- Grants
- $600K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.9M
- 3 awards · Health and Human S
- #234 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201020112012201320142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · TAS::75 0849::TAS | $195,550 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Other Functions - R&d Biomedical (basic Research) | $199,969 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Topic 277:PHASE 0 Carboplatin Microdosing Diagnostic Trial | $1,470,061 | |
| Federal grant | Department of Health and Human Services · Phase I · Feasibility of predicting AML response to induction chemotherapy | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Feasibility of predicting AML response to induction chemotherapy | $299,999 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 231 | EarlySense | $1.9M | — |
| 232 | ARETECH, LLC | $1.9M | — |
| 233 | Natera | $1.9M | — |
| 234 | ACCELERATED MEDICAL DIAGNOSTICS, INC | $1.9M | — |
| 235 | SYLVATICA BIOTECH INC | $1.8M | — |
| 236 | Redbud Labs, Inc. | $1.8M | $520K |
| 237 | Particle Metrix | $1.8M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.